GlassScriptPhysician profile
Jade Guevara
NPI 1780003459
$8,846.04
in general payments reported to CMS, 2019-2025
28 companies · $2,096 in 2025
The $2,096 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $146 · 2021: $829 · 2022: $2,314 · 2023: $767 · 2024: $2,289 · 2025: $2,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,288 · Travel and Lodging: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,288.21 |
| Travel and Lodging | $863.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,405.21 | 2019-2025 | Lensx, Clareon, Luxor |
| Biotissue Holdings INC. | $1,875.82 | 2019-2025 | |
| Abbvie INC. | $1,053.32 | 2022-2025 | |
| Allergan, INC. | $778.15 | 2019-2022 | |
| Dompe US, INC. | $374.78 | 2020-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $299.56 | 2023-2025 | Miebo, Envista Mx60 Iol, Doctors Allergy Formula |
| New World Medical,INC. | $297.55 | 2023-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Johnson & Johnson Surgical Vision, INC. | $289.19 | 2019-2022 | |
| Vb Spine LLC | $163.86 | 2025 | Everest Spinal System |
| Aerie Pharmaceuticals, INC. | $156.50 | 2019-2021 | |
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 | |
| Csl Behring | $125.00 | 2025 | Kcentra |
| Sun Pharmaceutical Industries INC. | $122.31 | 2020-2022 | |
| Harrow Eye, LLC | $120.61 | 2024-2025 | Vevye |
| W. L. Gore & Associates, INC. | $100.72 | 2024 | Gore Enform Preperitoneal Biomaterial |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $92.95 | 2024 | Tepezza |
| Mallinckrodt Hospital Products INC. | $77.84 | 2023-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $72.48 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $64.80 | 2024-2025 | Xdemvy |
| Topcon Healthcare, INC. | $48.83 | 2025 | |
| Rxsight INC | $37.33 | 2022-2023 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Astellas Pharma US INC | $29.25 | 2025 | Izervay |
| Rayner Intraocular Lenses Limited | $27.22 | 2025 | Rayone Spheric, Rayone Emv, Rayner Cataract Set 1 |
| Ani Pharmaceuticals, INC. | $24.60 | 2025 | Iluvien |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.84 | 2019 | |
| Glaukos Corporation | $21.61 | 2024 | Radius |
| Oyster Point Pharma, INC. | $21.30 | 2024 | Ryzumvi, Tyrvaya |
| Sight Sciences, INC. | $15.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Guevara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.